Ocular Therapeutix Inc. buy Royal Bank of Canada
Start price
18.03.25
/
50%
€6.81
Target price
18.03.26
€15.58
Performance (%)
7.64%
End price
19.03.26
€7.33
Summary
This prediction ended on 19.03.26 with a price of €7.33. The BUY prediction by Royal_Bank_of_Canada finished with a performance of 7.64%. Royal_Bank_of_Canada has a follow-up prediction for Ocular Therapeutix Inc. where he still thinks Ocular Therapeutix Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ocular Therapeutix Inc. | 11.333% | 11.333% | 32.498% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
In the thread Trading Ocular Therapeutix Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Ocular Therapeutix Inc.
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€9.41
05.11.25
05.11.25
-
05.11.26
05.11.26
-11.23%
17.04.26
17.04.26
